TELA Bio, Inc.TELANASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +25.94% | +3.83% | +11.55% | +25.52% | +9.14% |
| Gross Profit Growth | +23.77% | -3.47% | +10.37% | +27.38% | +8.64% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +0.90% | +63.64% | +84.17% | +83.94% | +83.87% |
| Weighted Average Shares Diluted Growth | +0.90% | +63.64% | +84.17% | +83.94% | +83.87% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +43.98% | +3.71% | +13.67% | +33.40% | +13.35% |
| Inventory Growth | -5.05% | -2.89% | -0.51% | -14.96% | -15.01% |
| Asset Growth | -39.28% | +11.89% | +7.54% | +12.18% | +16.17% |
| Book Value per Share Growth | +0.00% | -7.89% | -31.59% | +73.97% | +0.00% |
| Debt Growth | -0.59% | +0.69% | +1.39% | +1.24% | +1.17% |
| R&D Expense Growth | -12.67% | -24.43% | +6.14% | -5.17% | +13.54% |
| SG&A Expenses Growth | +10.73% | -17.30% | -4.24% | +3.26% | -4.86% |